a strong trendP = 0.034
The presence of the high-affinity FCGR2A - 131H allele in either homo/heterozygous combinations (HH and HR) in PsA patients receiving etanercept showed a strong trend to a higher rate of EULAR response compared with those without a response (93 vs. 67 %; P = 0.034) [ 17 ].